Company
Akari Therapeutics Plc (AKTX)
Standardized SEC financial data for Akari Therapeutics Plc — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001541157 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-61.1%
Free cash flow
-$10.6M
Current ratio
0.44×
EPS (diluted)
$0.00
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $8.8M | $9.1M | $9.6M | $5.5M | $7.0M | $2.8M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.1M | $9.4M | $13.3M | $3.8M | $2.7M | $5.3M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$17.0M | -$18.8M | -$21.5M | -$16.4M | -$12.6M | -$10.6M |
| Investing cash flow |
Get AKTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AKTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AKTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"